Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium by Sasieni, P et al.
Risk of preterm birth following surgical
treatment for cervical disease: executive
summary of a recent symposium
P Sasieni,a A Castanon,a R Landy,a M Kyrgiou,b H Kitchener,c M Quigley,d LCY Poon,e A Shennan,f
A Hollingworth,a WP Soutter,b T Freeman-Wang,g D Peebles,h W Prendiville,i J Patnickj
a Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK b Institute of
Reproduction and Developmental Biology, Department of Surgery & Cancer, Imperial College, London, UK c Institute of Cancer Sciences, St
Mary’s Hospital, University of Manchester, Manchester, UK d National Perinatal Epidemiology Unit, University of Oxford, Oxford, UK
e Harris Birthright Research Centre for Fetal Medicine, King’s College Hospital, London, UK f Women’s Health Academic Centre, King’s
College London, London, UK g Department of Gynaecology, Whittington Health, London, UK h Institute for Women’s Health UCL, London,
UK i International Agency for Research on Cancer, World Health Organization, Lyon, France j NHS Cancer Screening Programmes, Public
Health England, Sheffield, UK
Correspondence: Prof. P Sasieni, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London,
EC1M 6BQ, UK. Email p.sasieni@qmul.ac.uk
Accepted 5 November 2015. Published online 23 December 2015.
Please cite this paper as: Sasieni P, Castanon A, Landy R, Kyrgiou M, Kitchener H, Quigley M, Poon LCY, Shennan A, Hollingworth A, Soutter WP,
Freeman Wang T, Peebles D, Prendiville W, Patnick J. Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent
symposium. BJOG 2015; DOI: 10.1111/1471-0528.13839.
We report on a symposium held in London, UK, on
16 February 2015 to discuss the association between surgical
treatment of cervical intraepithelial neoplasia (CIN) and
subsequent preterm birth, and to consider appropriate rec-
ommendations for the treatment of CIN and management
of treated women during pregnancy. The meeting focused
on CIN grades 2 and 3 that have been managed surgically.
Clinical practice varies internationally: in some countries
knife excision is common; in others, laser ablation is the
treatment of choice; and in others, treatment predominantly
involves outpatient large loop excision of the transformation
zone (LLETZ), also called loop electrosurgical excision pro-
cedure (LEEP). The meeting was part of the dissemination
strategy of the National Institute for Health Research
(NIHR)-funded PaCT study (preterm delivery after treat-
ment of the cervical transformation zone). Around 50 peo-
ple attended, including gynaecologic oncologists, (nurse and
medical) colposcopists, obstetricians, and epidemiologists.
The authors of this executive summary include the speakers
at the symposium, who are also authors of important papers
in the subject area, and the symposium chairs, to provide an
independent opinion on the views expressed by the audi-
ence. Further details on the expertise of the authors can be
found in the contribution to authorship.
Meta-analysis suggested that pregnant women previously
treated by LLETZ are at approximately twice the risk of a
preterm birth than pregnant women in general.1–3 A study
from England,4 and a recent meta-analysis,3 found a much
lower relative risk and no association after adjusting for con-
founding factors. More recent research suggests that the
increased risk may be associated with large excisions alone
(10–14 mm, and particularly >15 mm), and that the reason
for the lack of association in some studies was that the
majority of women treated had small excisions.5 Assuming
the observed associations are causal, how should guidelines
be modified to minimise the risk of causing preterm deliver-
ies whilst still effectively preventing progression from CIN
to invasive cervical cancer? In thinking about the balance
between the harms and benefits of treatment it is important
to know about the long-term consequences of late preterm
deliveries (34–36 weeks of gestation). Even if the association
between LLETZ and preterm birth is not causal, having
identified a high-risk group there is a question as to how
they should be managed obstetrically.
The first part of the meeting focused on the results of
international studies on the association between the treat-
ment of CIN and subsequent risk of preterm delivery.
1 There is strong observational (but no experimental) evi-
dence [level 2a6] suggesting a causal link between treat-
ment for CIN and subsequent preterm birth, meeting
most of the Bradford Hill criteria for causation.
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Commentary
a Consistency. There is a strong and consistent associa-
tion between LLETZ and subsequent preterm birth,
summarised in meta-analyses and observed in several
countries.1,7,8
b Biological gradient. More aggressive forms of treat-
ment (e.g. knife cones) are more strongly associated
with preterm birth.1 There is a greater risk of pre-
term delivery with increasing length/volume of tissue
removed.1,5,9 Ablative treatment, generally reserved
for smaller lesions, has not been associated with pre-
term birth.1
c Temporality. There is no such gradient when the
birth precedes the treatment.16
d Specificity. Women who receive a diagnostic punch
biopsy at colposcopy before delivery have a similar
risk as those who have <10 mm (defined as the dis-
tance from the distal or external margin to the prox-
imal or internal margin of the excised specimen)10 of
cervical tissue excised.5
e Strength. The risk of preterm birth per pregnancy
increased with increasing length of excision, to
around one in six in women who have more than
20 mm of tissue removed.5
f Specificity. There is evidence that the association is
greater when the analysis is restricted to women who
have spontaneous onset of labour resulting in a pre-
term birth. The association also exists for late mid-
trimester miscarriages and very preterm births (at
20–31 weeks of gestation).1,11
g Plausibility. There are three plausible mechanisms by
which treatment could increase the risk of preterm
birth: a mechanical weakening of the cervix; more
subtle histological changes in the healed cervix, affect-
ing the tensile strength; impaired cervical antimicro-
bial mechanisms, such as mucus plug formation,
allowing microbial access to the uterine cavity.11
2 There is evidence (level 2b) that it does not hamper con-
ception following treatment.12,13
3 There is evidence (level 2b) that the time from treatment
to conception does not influence the risk of a preterm
birth,5 provided that conception does not happen within
4 months of treatment.14,15
4 There is some evidence (level 2b) to suggest that the age
at treatment does not influence the risk of a preterm
birth.16
5 The increased risk of preterm birth is not limited to the
first birth after treatment (level 2b). Even women who
have a term birth after a large excision (>15 mm length)
are at increased risk of preterm delivery during future
pregnancies.16
The second part of the meeting aimed to put the evi-
dence regarding the risk of preterm birth in the context of
the wider aims of cervical screening (to prevent cervical
cancer by appropriate treatment of precancerous lesions).
The speakers explored the use of ablative treatment in col-
poscopy and the need for quality assurance of the pro-
gramme.
There was consensus (level 5) among the audience on
the following points.
1 Quality management of colposcopy is essential.
2 The volume of material excised may often be excessive.
3 It is important to find a way of recording the length of
excision in the primary care notes.
4 Excision of high-grade CIN should aim to result in mar-
gins that are clear of disease.
5 Complete excision of a CIN grade 3 should not be jeop-
ardised for the sake of reducing the risk of a preterm
birth.
6 Ablative treatments, including thermo-coagulation, have
an important role in low- and middle-income countries.
There was a lack of consensus regarding ablative treat-
ment. The majority view was that ablative treatment is not,
at this time, an appropriate alternative to LLETZ in estab-
lished cervical screening programmes in high-income coun-
tries. Concern was raised regarding the risk of invasive
cancer after destructive treatments.17,18 Others felt that
ablative treatment is safe for CIN2 and for type–I transfor-
mation zone (defined as completely ectocervical and fully
visible),19 and was less likely to result in over treatment
(and increased risk of preterm birth) when carried out by a
less experienced colposcopist. The counter argument was
that without measurements of the volume of tissue
destroyed, and without evidence of whether there were
clear margins or occult invasive cancer, it was impossible
to quality assure ablative treatment. The majority view was
that ablative treatments are acceptable for CIN2, provided
the whole lesion is visualised.
Although a randomised controlled trial of ablative treat-
ment versus excision for type–I lesions was proposed, it
was agreed that any such trial would need to be extremely
large and to have long-term follow-up. The majority view
was that such a trial was not justified, taking into account
that small excision appears to be safe and that the future
demand for treatment of CIN3 will be dramatically reduced
by human papilloma virus (HPV) vaccination.
Finally, the meeting focused on the long-term impact of
preterm birth and the obstetric management of high-risk
pregnancies. There is growing evidence of small effects on
health and behaviour in children born late preterm com-
pared with those born at 40 weeks of gestation (level 2b).
For instance, 16.6% of infants born at 33–34 weeks of ges-
tation and 13.5% of infants born at 35–36 weeks of gesta-
tion had an emergency hospital admission for respiratory
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disease by the age of 1 year, compared with 7.8% of those
born at 40–42 weeks of gestation.20 Similarly, children born
at 33–36 weeks of gestation were 50% more likely to have
special educational needs than those born at 40 weeks of
gestation.21 The impact of moderate and late preterm birth
even continues into adulthood. A large study from Sweden
found that those born at 33–36 weeks of gestation were
50% (95% confidence interval, 95% CI 30–70%) more
likely to receive a sickness pension, handicap allowance, or
disability assistance than those born at 39–41 weeks of ges-
tation, after adjusting for several risk factors.22
A number of studies have shown short cervical length
measured by ultrasound during pregnancy (16–24 weeks of
gestation) to be predictive of spontaneous preterm (and in
particular early preterm) delivery in women previously
treated by LLETZ (level 2b), but it is uncertain whether
LLETZ (particularly >20 mm in length) confers additional
risk after accounting for cervical length.23,24
High levels of fetal fibronectin, an extracellular matrix
glycoprotein found in cervicovaginal secretions, from
22 weeks of gestation are strongly associated with early
(<30 weeks of gestation) preterm delivery (level 2b). Its
role in predicting late preterm delivery is less clear.
Various interventions have been shown to prevent pre-
term delivery in women with a short cervix (≤25 mm). The
level of evidence for interventions to prevent preterm birth
in very high-risk women is strong, but none have specifi-
cally studied women whose increased risk was a conse-
quence of previous LLETZ. Cervical cerclage does not
reduce the risk of singleton preterm labour when the only
risk factor is a short cervix discovered incidentally, but
benefit has been reported in a subgroup of high-risk
women (those with cervical lengths of <15 mm).25 An indi-
vidual patient data meta-analysis including five small trials
of mid-trimester vaginal progesterone treatment showed a
reduction in preterm birth <35 weeks of gestation (relative
risk 0.69; 95% CI 0.55–0.88).26 The results of randomised
studies of cervical pessary in the prevention of preterm
birth are inconsistent.27
The consensus is outlined as follows.
1 Predictors of preterm birth, including cervical length
and fetal fibronectin, can be used to ascertain risk in
women following surgical treatment of high-grade CIN
(grade C).
2 There is no evidence to suggest that cerclage, vaginal
pessary, or progesterone are less effective in women trea-
ted by LLETZ.
3 Women who have had a large excision (>15 mm in
length) of their cervical transformation zone should be
identified during pregnancy and managed in the knowl-
edge that they are at moderately increased risk of a pre-
term delivery (grade D).
4 Research into the management of women in pregnancy
with prior LLETZ is required, including risk thresholds
and types of prophylactic interventions that are effica-
cious.
Overall, the participants made the following recommen-
dations.
1 Basic research is required to better understand the mech-
anism by which excision is associated with preterm
births (grade D).
2 Publications on this topic should use the following cate-
gories for the length of the excised cone (measured on
pathology): 1–9, 10–14, 14–19, and ≥20 mm (grade D).
3 Excisions of less than 10 mm in length appear to have,
at most, minimal affect on the risk of preterm births
(grade B).
4 Auditing standards are needed for the length of excision
in cervical screening programmes. We suggest the fol-
lowing guidelines.
a When treating a type–I transformation zone (defined
as completely ectocervical and fully visible, it may be
small or large) in a woman of childbearing age, 80%
of excisions should be <10 mm and 95% should be
<15 mm (grade C).
b When treating a type–II transformation zone (i.e.
including an endocervical component, fully visible,
and may have an ectocervical component that may be
small or large) in a woman of childbearing age, 50%
of excisions should be <10 mm and 80% should be
<15 mm (grade C).
5 CIN2 (particularly if p16-negative) in a woman of child-
bearing age should not automatically be treated but
should be discussed at the multidisciplinary team meet-
ing (grade D).
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